4302-2507 Screening compound: (4Z)-3-(4-methoxyphenyl)-1-(4-nitrophenyl)-4-{[(2,2,6,6-tetramethylpiperidin-4-yl)amino]methylidene}-4,5-dihydro-1H-pyrazol-5-one

4302-2507 Screening compound: (4Z)-3-(4-methoxyphenyl)-1-(4-nitrophenyl)-4-{[(2,2,6,6-tetramethylpiperidin-4-yl)amino]methylidene}-4,5-dihydro-1H-pyrazol-5-one
4302-2507 Screening compound: (4Z)-3-(4-methoxyphenyl)-1-(4-nitrophenyl)-4-{[(2,2,6,6-tetramethylpiperidin-4-yl)amino]methylidene}-4,5-dihydro-1H-pyrazol-5-one alternative view

Chemical Structure Depiction of ChemDiv screening compound 4302-2507
(4Z)-3-(4-methoxyphenyl)-1-(4-nitrophenyl)-4-{[(2,2,6,6-tetramethylpiperidin-4-yl)amino]methylidene}-4,5-dihydro-1H-pyrazol-5-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

4302-2507

Molecular Formula

C26H31N5O4 (C26 H31 N5 O4)

Compound Name

(4Z)-3-(4-methoxyphenyl)-1-(4-nitrophenyl)-4-{[(2,2,6,6-tetramethylpiperidin-4-yl)amino]methylidene}-4,5-dihydro-1H-pyrazol-5-one

IUPAC name

(4Z)-3-(4-methoxyphenyl)-1-(4-nitrophenyl)-4-{[(2266-tetramethylpiperidin-4-yl)amino]methylidene}-45-dihydro-1H-pyrazol-5-one

SMILES

CC(C)(C1)NC(C)(C)CC1N/C=C(/C(c(cc1)ccc1OC)=NN1c(cc2)ccc2[N+]([O-])=O)\C1=O

InChI

InChI=1S/C26H31N5O4/c1-25(2)14-18(15-26(3,4)29-25)27-16-22-23(17-6-12-21(35-5)13-7-17)28-30(24(22)32)19-8-10-20(11-9-19)31(33)34/h6-13,16,18,27,29H,14-15H2,1-5H3

InChI Key

HJAACQGWQRQAJL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD03139587

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

477.56

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.470

Distribution Coefficient, logD

-0.009

Water Solubility, LogSw

-3.63

Polar Surface Area

90.837

Acid Dissociation Constant (pKa)

14.55

Base Dissociation Constant (pKb)

10.88

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

38.50

4302-2507 in Drug Discovery

Included in Screening Libraries

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with 4302-2507 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 4302-2507?
Check Price and Availability of 4302-2507, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 4302-2507 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 4302-2507
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 4302-2507
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 4302-2507 available by request